The study aimed to evaluate COVID-19 vaccine uptake, reasons for hesitancy, and self-reported disease flare in a large network of rheumatology practices.
Out of 61,158 patients surveyed, 89% had received at least one vaccine dose, but those with autoimmune and inflammatory rheumatic diseases (AIIRDs) were less likely to be vaccinated and more hesitant compared to those without AIIRDs.
Main reasons for hesitancy included safety concerns and side effects, while a lack of physician recommendation was a key factor for booster hesitancy; however, having AIIRD did not lead to higher rates of self-reported disease flare after vaccination.